DevExplains: Vaccine-derived polio and the challenge of eradication

MANILA — The Global Commission for the Certification of the Eradication of Poliomyelitis is expected to announce a major milestone this week: the global eradication of wild poliovirus type 3.

The announcement will mean there’s only one wild poliovirus still in circulation — type 1, in Afghanistan and Pakistan — considered the last frontiers of the fight against the disease.

But several countries’ weak health systems and the scourge of vaccine skepticism worldwide are posing challenges to polio eradication efforts.

This story is forDevex Pro members

Unlock this story now with a 15-day free trial of Devex Pro.

With a Devex Pro subscription you'll get access to deeper analysis and exclusive insights from our reporters and analysts.

Start your free trial